Search Tag: gadolinium
2021 26 Oct
Gadolinium-based contrast agents (GBCAs), used during MRI scans, enhance brain tissue contrast. GBCAs are crucial for brain tumour care because they highlight areas with abnormal blood-brain barrier permeability that tumours cause. This permits monitoring of treatment response and also guide surgical tumour removal. Disadvantages to using GBCAs include...Read more
2019 13 Feb
Executive Summary Prof. Paul Sidhu , President of the European Federation of Societies for Ultrasound in Medicine and Biology ( EFSUMB ), shares with Healthmanagement.org a preview of his presentations at the forthcoming ECR 2019 . The use of ultrasound simulation models as tools in training and education is among the important...Read more
2017 27 Nov
International medical imaging IT and cybersecurity company Sectra is globally introducing gadolinium tracking in its dose monitoring solution, Sectra DoseTrack. Gadolinium is a contrast agent commonly used to enhance images during MRI exams. By systematically registering gadolinium information, healthcare providers can reduce the risk of patients...Read more
2016 05 Jul
A study of about 247,000 elderly patients who were subject to gadolinium-enhanced MRIs has shown that there was no significant association between exposure to the contrast agent and parkinsonism. The study was conducted because of growing safety concerns over retained gadolinium in the globus pallidi (an area of the brain), whereas neurotoxic...Read more
2016 05 Mar
Over the past 25 years, gadolinium-based contrast agents (GBCA) have been recognised to have exceptional safety profiles with minimal side effects, as three researchers showed in their presentations at the European Congress of Radiology (ECR 2016) in Vienna. Dr. Richard Semelka of the Department of Radiology, University of North Carolina...Read more
2015 28 Jun
A new study, published in the journal Investigative Radiology , indicates that repeated use of specific “linear”-type gadolinium-based contrast agents (GBCAs) — widely used for diagnostic MRI scans — can lead to deposits of the heavy-metal element gadolinium in the brain. The findings could have a major impact on the multimillion-dollar market for...Read more